Literature DB >> 7035498

Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.

A To, D V Coleman, D P Dearnaley, M G Ormerod, K Steele, A M Neville.   

Abstract

A new human antigen, designated epithelial membrane antigen (EMA), has recently been described on surface membranes of a wide variety of normal epithelium but not on connective tissue cells. The antigen is only weakly expressed on normal or reactive mesothelium. Increased expression of the antigen has been observed in most neoplasms of epithelial origin and in malignant mesothelioma. We have investigated the possibility of using this difference in the expression of the antigen to distinguish between mesothelial cells and malignant cells in cytological smears of serous effusions. This distinction cannot always be made on morphological grounds alone and problems of differential diagnosis are encountered in about 15% of all specimens of serous effusions sent for cytological examination. Using antisera to EMA we have applied an indirect immunoalkaline phosphatase technique to alcohol-fixed smears prepared from serous effusions and have found that intense staining of the antigen is confined to effusions from patients in whom there is either clinical or cytological evidence of malignancy. The technique proved to be especially useful in cytologically equivocal cases, where there were problems of differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7035498      PMCID: PMC494588          DOI: 10.1136/jcp.34.12.1326

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1971-12

2.  Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology.

Authors:  J P Sloane; M G Ormerod
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

3.  CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study.

Authors:  M J O'Brien; S E Kirkham; B Burke; M Ormerod; C A Saravis; L S Gottlieb; A M Neville; N Zamcheck
Journal:  Invest Cell Pathol       Date:  1980 Jul-Sep

4.  The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.

Authors:  J P Sloane; M G Ormerod; S F Imrie; R C Coombes
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

  4 in total
  24 in total

1.  Carcinocythemia. A terminal manifestation of metastatic breast cancer.

Authors:  D M Aboulafia
Journal:  West J Med       Date:  1992-12

2.  Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.

Authors:  A Linari; G Bussolati
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

3.  AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.

Authors:  G Kocjan; E Sweeney; K D Miller; L Bobrow
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

4.  Distinction between cells in serous effusions using a panel of antibodies.

Authors:  A F Lauritzen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.

Authors:  A K Ghosh; A I Spriggs; J Taylor-Papadimitriou; D Y Mason
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

6.  Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.

Authors:  A Herbert; P J Gallagher
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

7.  Towards an automated procedure for the quantitative cytological screening of cervical neoplasms.

Authors:  A M Sincock; J Middleton; D Moncrieff
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

8.  Some aspects of the detection of malignant cells in pleural and peritoneal effusions and comparison with serosal biopsies.

Authors:  W F Kealy
Journal:  Ir J Med Sci       Date:  1985-08       Impact factor: 1.568

9.  Lectin binding properties of cells from serous effusion and peritoneal washing specimens.

Authors:  P W Shield
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

10.  The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).

Authors:  C A Szpak; W W Johnston; V Roggli; J Kolbeck; S C Lottich; R Vollmer; A Thor; J Schlom
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.